Validation of the Test of Adherence to Inhalers (TAI) among Taiwanese Patients with Chronic Obstructive Pulmonary Disease
Medical Science Monitor · 2025
DOI: 10.12659/msm.948762 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Medical Science Monitor, 2025. Verfasst von Yin-Han Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Therapy, Chang Gung Memorial Hospital, Chiayi, Taiwan. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Nebulizers and Vaporizers, Medication Adherence, Patient Compliance. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: COPD
Abstract (Originalsprache)
BACKGROUND It is important to have a psychometrically sound instrument assessing inhaler adherence of patients with chronic obstructive pulmonary disease (COPD). The present cross-cultural study aimed to validate the Chinese translation of the 10-item Test of Adherence to Inhalers (TAI) among 235 Taiwanese patients with COPD. MATERIAL AND METHODS The TAI was translated into Chinese and validated for Taiwanese patients with COPD. Eight experts evaluated the Chinese TAI, and their scores were used to examine content validity. Then, a total of 235 COPD patients (93.6% male, n=220; mean age=72.18 years, SD=10.19) were recruited using convenience sampling. A research assistant and a respiratory therapist conducted interviews to help patients complete the TAI and other related measures. Exploratory factor analysis, internal consistency, and relationship between TAI-defined adherence groups and the statement "Don't take medicine when there are no symptoms" were used to validate the Chinese TAI. RESULTS The content validity and internal consistency of the Chinese TAI were good (content validity index=0.975 for relevance, and 0.988 for clarity; alpha=0.82). The exploratory factor analysis suggested a single-factor structure. Moreover, the TAI-defined adherence groups had significantly different responses to the statement "Don't take medicine when there are no symptoms". CONCLUSIONS The Chinese TAI assessing inhaler adherence among Taiwanese patients with COPD effectively helps patients with COPD to identify their inhaler adherence. Researchers and healthcare providers can use the translated TAI to monitor adherence to inhaler for patients with COPD in Taiwan.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Respiratory Therapy, Chang Gung Memorial Hospital, Chiayi, Taiwan.
- Division of Pulmonary and Critical Care Medicine, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan.
- Department of Respiratory Care, Chang Gung University of Science and Technology, Chiayi, Taiwan.
- Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Department of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Department of Internal Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan.
ORCID-Profile: Tsung-Ming Yang, Huang-Tzu Ou, Szu-Chun Yang
Zitieren
APA
Wang, Y. H., Yang, T. M., Fang, T. P., Ou, H. T., Yang, S. C., Huang, C. M., Griffiths, M. D., & Lin, C. Y. (2025). Validation of the Test of Adherence to Inhalers (TAI) among Taiwanese Patients with Chronic Obstructive Pulmonary Disease. Medical Science Monitor. https://doi.org/10.12659/msm.948762
Vancouver
Wang YH, Yang TM, Fang TP, Ou HT, Yang SC, Huang CM, et al. Validation of the Test of Adherence to Inhalers (TAI) among Taiwanese Patients with Chronic Obstructive Pulmonary Disease. Medical Science Monitor. 2025. doi:10.12659/msm.948762
BibTeX
@article{Wang2025,
author = {Wang, Yin-Han and Yang, Tsung-Ming and Fang, Tien-Pei and Ou, Huang-Tzu and Yang, Szu-Chun and Huang, Chun-Mei and Griffiths, Mark D and Lin, Chung-Ying},
title = {Validation of the Test of Adherence to Inhalers (TAI) among Taiwanese Patients with Chronic Obstructive Pulmonary Disease},
journal = {Medical Science Monitor},
year = {2025},
doi = {10.12659/msm.948762}
}
EUVIMED